PDGFRB and cancer: Therefore, it can be speculated that besides direct inhibitory effects of Sema3A-Nrp1 interaction on PDGF-induced HASMC proliferation, Nrp1 might compete with PDGFR to bind its ligand which, unlike cancer studies [52], further weakened the cellular function.